Literature DB >> 26593445

Non-hormonal male contraception: A review and development of an Eppin based contraceptive.

Michael G O'Rand1, Erick J R Silva2, Katherine G Hamil3.   

Abstract

Developing a non-hormonal male contraceptive requires identifying and characterizing an appropriate target and demonstrating its essential role in reproduction. Here we review the development of male contraceptive targets and the current therapeutic agents under consideration. In addition, the development of EPPIN as a target for contraception is reviewed. EPPIN is a well characterized surface protein on human spermatozoa that has an essential function in primate reproduction. EPPIN is discussed as an example of target development, testing in non-human primates, and the search for small organic compounds that mimic contraceptive antibodies; binding EPPIN and blocking sperm motility. Although many hurdles remain before the success of a non-hormonal male contraceptive, continued persistence should yield a marketable product.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EPPIN; Male contraception; Reproductive pharmacology; Semenogelin; Sperm

Mesh:

Substances:

Year:  2015        PMID: 26593445      PMCID: PMC4703502          DOI: 10.1016/j.pharmthera.2015.11.004

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  69 in total

1.  Autoantibodies against spermatozoa in sterile men.

Authors:  P RUMKE; G HELLINGA
Journal:  Am J Clin Pathol       Date:  1959-10       Impact factor: 2.493

2.  Analysis of recombinant human semenogelin as an inhibitor of human sperm motility.

Authors:  Anurag Mitra; Richard T Richardson; Michael G O'Rand
Journal:  Biol Reprod       Date:  2009-11-04       Impact factor: 4.285

Review 3.  Epididymal protein targets: a brief history of the development of epididymal protease inhibitor as a contraceptive.

Authors:  Michael G O'Rand; Esther E Widgren; Katherine G Hamil; Erick J Silva; Richard T Richardson
Journal:  J Androl       Date:  2011-03-25

4.  Infertility in female rabbits isoimmunized with subcellular sperm fractions.

Authors:  M G Munoz; C B Metz
Journal:  Biol Reprod       Date:  1978-05       Impact factor: 4.285

5.  Appearance of cell surface auto- and isoantigens during spermatogenesis in the rabbit.

Authors:  M G O'Rand; L J Romrell
Journal:  Dev Biol       Date:  1977-02       Impact factor: 3.582

6.  Suppression of spermatogenesis by bisdichloroacetyldiamines is mediated by inhibition of testicular retinoic acid biosynthesis.

Authors:  John K Amory; Charles H Muller; Jakob A Shimshoni; Nina Isoherranen; Jisun Paik; Jan S Moreb; David W Amory; Ryan Evanoff; Alex S Goldstein; Michael D Griswold
Journal:  J Androl       Date:  2010-08-12

7.  The c-ros tyrosine kinase receptor controls regionalization and differentiation of epithelial cells in the epididymis.

Authors:  E Sonnenberg-Riethmacher; B Walter; D Riethmacher; S Gödecke; C Birchmeier
Journal:  Genes Dev       Date:  1996-05-15       Impact factor: 11.361

8.  Characterization of EPPIN's semenogelin I binding site: a contraceptive drug target.

Authors:  Erick J R Silva; Katherine G Hamil; Richard T Richardson; Michael G O'Rand
Journal:  Biol Reprod       Date:  2012-09-07       Impact factor: 4.285

9.  Expression of the gene for mouse lactate dehydrogenase C (Ldhc) is required for male fertility.

Authors:  Fanny Odet; Chongwen Duan; William D Willis; Eugenia H Goulding; Aisha Kung; Edward M Eddy; Erwin Goldberg
Journal:  Biol Reprod       Date:  2008-03-26       Impact factor: 4.285

Review 10.  Eppin: an epididymal protease inhibitor and a target for male contraception.

Authors:  M G O'Rand; E E Widgren; Zengjun Wang; R T Richardson
Journal:  Soc Reprod Fertil Suppl       Date:  2007
View more
  19 in total

1.  A prospective double-blind, randomized, placebo-controlled study to evaluate the efficacy of silodosin 8 mg as an on-demand, reversible, nonhormonal oral contraceptive for males: a pilot study.

Authors:  Gajanan S Bhat; Anuradha Shastry
Journal:  World J Urol       Date:  2019-05-10       Impact factor: 4.226

2.  Hormonal Male Contraception: Getting to Market.

Authors:  Stephanie T Page; Diana Blithe; Christina Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

Review 3.  Pipeline for contraceptive development.

Authors:  Diana L Blithe
Journal:  Fertil Steril       Date:  2016-08-11       Impact factor: 7.329

4.  Evaluation of a Zinc Gluconate Neutralized with Arginine Product as a Nonsurgical Method for Sterilization of Rhesus Macaques (Macaca mulatta).

Authors:  Kacie N Woodward; Rebekah I Keesler; J Rachel Reader; Kari L Christe
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-09-01       Impact factor: 1.232

Review 5.  Contraception: Search for an Ideal Unisex Mechanism by Targeting Ion Channels.

Authors:  Polina V Lishko
Journal:  Trends Biochem Sci       Date:  2016-08-18       Impact factor: 13.807

Review 6.  Current and future contraceptive options for women living with HIV.

Authors:  Rena C Patel; Elizabeth A Bukusi; Jared M Baeten
Journal:  Expert Opin Pharmacother       Date:  2017-09-19       Impact factor: 3.889

Review 7.  Emerging approaches to male contraception.

Authors:  Arthi Thirumalai; John K Amory
Journal:  Fertil Steril       Date:  2021-04-27       Impact factor: 7.490

8.  A genomic atlas of human adrenal and gonad development.

Authors:  Ignacio Del Valle; Federica Buonocore; Andrew J Duncan; Lin Lin; Martino Barenco; Rahul Parnaik; Sonia Shah; Mike Hubank; Dianne Gerrelli; John C Achermann
Journal:  Wellcome Open Res       Date:  2017-04-07

9.  Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive.

Authors:  Michael G O'Rand; Katherine G Hamil; Tiffany Adevai; Mary Zelinski
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

10.  Are men ready to use thermal male contraception? Acceptability in two French populations: New fathers and new providers.

Authors:  Marie Amouroux; Roger Mieusset; Raoul Desbriere; Pierre Opinel; Gilles Karsenty; Marine Paci; Sara Fernandes; Blandine Courbiere; Jeanne Perrin
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.